NuVasive introduced its C360™ cervical spine portfolio, including commercial launch of the Anterior Cervical Plating (ACP) system, featuring what is reported to be the thinnest plate on the market at 1.6 mm.
The new ACP system is designed to help reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification. The customizable treatment comprises:
- Three plate profiles, including the thinnest plate on the market for one and two levels, with optimized plate stiffness for each surgical level to support construct stability
- An array of implant length options to match a variety of patient anatomies and to facilitate maximizing the distance from the adjacent levels
- A range of screw offerings with integrated locking covers to enable better screw placement and locking accuracy
The C360 portfolio includes Reline® Cervical, a posterior fixation system slated for launch in 2021. The portfolio integrates with access instrumentation, implants, enabling technologies and biologic materials to offer a procedural solution.
The company increased its R&D spend by about $1 million each quarter this year while executing on its “innovation roadmap.” C360 is among various products mentioned in the company's 3Q20 earnings coverage for launch by year-end.
"The unveiling of the C360 portfolio reflects NuVasive's commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine...NuVasive saw an opportunity to procedurally integrate technology to support the cervical spine—as it did in the lateral market with X360®—to optimize the surgeon experience and advance care in the operating room." –Massimo Calafiore, Executive Vice President, Global Business Units